Shishira Bharadwaj, MD
Gastroenterology · Maywood, ILNPI 1457587172
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,395 of the $3,691 with a category attached, or 64.9%. Boston Scientific accounts for 67.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,691 and has fallen 99.2% since, to $21 in 2025.
Across 48 payments — averaging $76.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Apollo Endosurgery US Inc$744
- CSA Medical, Inc$146
- Conmed Corporation$125
- Medtronic$110
- GSK$39
- plus $37 from 2 others
What the payments were for
- Consulting fees$1103%
- Travel & lodging$2,39565%
- Food & beverage$1,18632%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 35 | $2,490 |
| Apollo Endosurgery US Inc | 6 | $744 |
| CSA Medical, Inc | 1 | $146 |
| Conmed Corporation | 1 | $125 |
| Medtronic | 1 | $110 |
| GSK | 2 | $39 |
| Shire North American Group Inc | 1 | $23 |
| Bristol Myers Squibb | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - BILIARY DEVICES$907
- GENERAL POLYPECTOMY$627
- Overstitch$546
- INTERJECT$315
- CONMED HEMOSTASIS$125
- CONMED BILIARY$125
- GENERAL METAL STENTS GI$117
- Beacon$110
How this compares
$3,691 in reported general payments places this provider in the 70th percentile of 787 gastroenterology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 17 | $277 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $213 |
| Pantoprazole Sodium | 11 | $95 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Maywood
- Abdelhai AbdelqaderMaywood$81K
- David RubinChicago$1.5M
- Stephen HanauerChicago$1.4M
- Steven FlammChicago$1.3M
- Amar NaikDes Plaines$1.2M
- Darren BrennerChicago$1.1M
- Jonathan RosenbergGurnee$1M
- Daksesh PatelEvanston$745K
- Russell CohenChicago$690K
- Parambir DulaiChicago$668K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.